Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/23/2026 | 220,007 | 0.1% | 285,031 | 12/31/2025 |
| 2025 Q3 | 10/27/2025 | 172,779 | 0.1% | 307,289 | 9/30/2025 |
| 2025 Q2 | 7/31/2025 | 161,797 | 0.1% | 308,185 | 6/30/2025 |
| 2025 Q1 | 4/25/2025 | 192,596 | 0.1% | 303,669 | 3/31/2025 |
| 2024 Q4 | 1/28/2025 | 215,562 | 0.1% | 302,616 | 12/31/2024 |
| 2024 Q3 | 11/5/2024 | 316,957 | 0.2% | 301,508 | 9/30/2024 |
| 2024 Q2 | 7/19/2024 | 312,831 | 0.2% | 297,642 | 6/30/2024 |
| 2024 Q1 | 4/19/2024 | 307,081 | 0.2% | 319,048 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 280,481 | 0.2% | 319,349 | 12/31/2023 |
| 2023 Q3 | 10/30/2023 | 270,195 | 0.2% | 328,321 | 9/30/2023 |
| 2023 Q2 | 7/31/2023 | 239,562 | 0.2% | 333,401 | 6/30/2023 |
| 2023 Q1 | 4/27/2023 | 306,596 | 0.2% | 373,138 | 3/31/2023 |
| 2022 Q4 | 1/30/2023 | 273,884 | 0.2% | 379,609 | 12/31/2022 |
| 2022 Q3 | 10/21/2022 | 269,452 | 0.2% | 391,150 | 9/30/2022 |
| 2022 Q2 | 7/26/2022 | 236,058 | 0.2% | 399,334 | 6/30/2022 |
| 2022 Q1 | 4/27/2022 | 284,029 | 0.2% | 406,674 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 272,952 | 0.2% | 432,215 | 12/31/2021 |
| 2021 Q3 | 10/25/2021 | 283,992 | 0.2% | 469,269 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 307,952 | 0.2% | 551,352 | 6/30/2021 |
| 2021 Q1 | 4/30/2021 | 234,609 | 0.1% | 495,855 | 3/31/2021 |
| 2020 Q4 | 2/5/2021 | 217,207 | 0.1% | 449,601 | 12/31/2020 |
| 2020 Q3 | 10/30/2020 | 257,819 | 0.2% | 460,572 | 9/30/2020 |
| 2020 Q2 | 7/27/2020 | 300,604 | 0.2% | 482,007 | 6/30/2020 |
| 2020 Q1 | 4/27/2020 | 195,873 | 0.2% | 401,140 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 174,907 | 0.1% | 465,823 | 12/31/2019 |
| 2014 Q2 | 8/11/2014 | 53,736 | 0.1% | 190,237 | 6/30/2014 |
| 2014 Q1 | 5/9/2014 | 58,901 | 0.1% | 196,152 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 53,994 | 0.1% | 194,167 | 12/31/2013 |